Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 CAD | -0.59% | +1.81% | -49.55% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.55% | 19.51M | |
+23.11% | 46.4B | |
-1.21% | 41.75B | |
+47.75% | 41.37B | |
-3.52% | 29.71B | |
+10.28% | 26.01B | |
-19.64% | 19.52B | |
+30.93% | 12.43B | |
-0.03% | 12.18B | |
-0.37% | 12.13B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Says Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML; Adds Tuspetinib "Continues Broad Activity Across Mutations with Excellent Safety Profile"